FDA to Speak at ISPE Conference
ISPE reports that the FDA's Deputy Commissioner for Medical Products and Tobacco, Stephen P. Spielberg, MD, PhD, will deliver a plenary address at the 2012 ISPE Annual Meeting, scheduled November 11-14 in San Francisco, CA. In "How the FDA is Advancing Regulatory Science through High Quality Collaboration," Spielberg will discuss how FDA is addressing challenges and taking advantage of opportunities to advance regulatory science through collaborations with organizations like ISPE, the group reported in a press release.
The session will also feature Murray Aitken, Executive Director, IMS Institute for Healthcare Informatics, who will present "Top Priorities and Trends for the Pharmaceutical Industry." It will serve as an analysis of the industry supported by quantifiable data, as well as a forecast of top priorities and trends through 2016, including content that will be exclusive to ISPE's Annual Meeting, ISPE reports in the release.
The session is part of a four-day conference program designed to give pharmaceutical professionals a better understanding of the industry's current technical and regulatory challenges and an opportunity to engage in open dialog to solve those challenges, ISPE reports. Two other sessions include:
Executive Series: Distinguished industry leaders will participate in a strategic discussion of key areas identified by technical leaders as critical to the future of the pharmaceutical industry. Attendees will hear "Confessions of a Counterfeiter," and other provocative discussion topics.
International Regulatory Summit: High-level regulators from North America, Europe, Asia and Latin America will discuss regional regulatory challenges and examine those challenges within the context of a global regulatory environment.
Watch this video to learn more about the 2012 ISPE Annual Meeting: